ClinVar Miner

Submissions for variant NM_000051.3(ATM):c.2502dup (p.Val835fs) (rs587779822)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000115156 SCV000187199 pathogenic Hereditary cancer-predisposing syndrome 2017-11-24 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
Color RCV000115156 SCV000682060 pathogenic Hereditary cancer-predisposing syndrome 2016-07-20 criteria provided, single submitter clinical testing
Counsyl RCV000410349 SCV000486972 pathogenic Ataxia-telangiectasia syndrome 2016-09-16 criteria provided, single submitter clinical testing
GeneDx RCV000235098 SCV000149065 pathogenic not provided 2018-10-01 criteria provided, single submitter clinical testing This duplication of one nucleotide in ATM is denoted c.2502dupA at the cDNA level and p.Val835SerfsX7 (V835SfsX7) at the protein level. The normal sequence, with the base that is duplicated in brackets, is GAGA[dupA]GTAG. The duplication causes a frameshift which changes a Valine to a Serine at codon 835, and creates a premature stop codon at position 7 of the new reading frame. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. ATM c.2502dupA, also reported as ATM 2502insA, has been observed in both the homozygous and compound heterozygous state in individuals with Ataxia-telengiectasia (Telatar 1998, Sandoval 1999, Chessa 2009). We consider this variant to be pathogenic.
Invitae RCV000410349 SCV000748965 pathogenic Ataxia-telangiectasia syndrome 2018-10-26 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Val835Serfs*7) in the ATM gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals and families with ataxia-telangiectasia (PMID: 9443866, 19691550, 15843990). It has also been reported in individuals with breast cancer and melanoma (PMID: 26681312, 26023681). This variant is also known as 2502insA, c.2502_2503insA p.(Val835fs), and 2503_2504insA in the literature. ClinVar contains an entry for this variant (Variation ID: 127351). Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.